Perioperative Use of Levosimendan in Hepatic Transplantation With Diastolic Heart Failure: A Case Report
Erick Villafán Vázquez, Ricardo Acuña Razo, Mayra Michelle Nuñez Rueda

TL;DR
This case report describes the use of levosimendan during liver transplantation in a patient with heart and lung issues.
Contribution
The paper presents a novel case of levosimendan use in hepatic transplantation with diastolic heart failure.
Findings
Levosimendan was used in a complex transplant case with diastolic heart failure and pulmonary hypertension.
Current evidence on levosimendan's perioperative use remains insufficient for standardized guidelines.
Abstract
Levosimendan is a medication with a range of pharmacological effects, making it appropriate for use in several clinical settings, including advanced heart failure with pulmonary hypertension, cardiogenic shock, and acute heart failure. This case report details the perioperative management of a male in their 40s with a complex medical history, including primary hypoparathyroidism, cirrhosis, and severe pulmonary hypertension, who underwent urgent cadaveric donor liver transplantation. Information available on the perioperative use of levosimendan is still insufficient to be able to regulate behaviors that can guide its management on a regular basis.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLiver Disease and Transplantation · Heart Failure Treatment and Management · Organ Transplantation Techniques and Outcomes
